• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

3.880 +0.010 (+0.26%)
Delayed Quote Updated: 10:27 AM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 136,303
Open 3.870
Bid (Size) 3.870 (1,300)
Ask (Size) 3.890 (300)
Prev. Close 3.870
Today's Range 3.830 - 4.000
52wk Range 3.350 - 8.740
Shares Outstanding 14,508,063
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
October 21, 2026
From Unicycive Therapeutics, Inc.
Via JCN Newswire
News headline image
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
October 21, 2026
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate... 
Via B2i Digital

Performance

52-Week Range 55.6% below 52-week high
3.880
3.3552W Low 8.7452W High
1 Week 7.2% below 1-week high
3.351W Low 4.181W High

Unicycive Therapeutics, Inc. - Common Stock (UNCY) traded between $3.35 and $8.74 over the past 52 weeks and last traded at $3.88, 55.6% below its 52-week high. Over the past week it ranged between $3.35 and $4.18.

Past 12 Months
+8.1%
-18.7%
-30.3%
-49.7%
-33.1%
-21.5%
1W +$0.29
1M -$0.89
3M -$1.69
6M -$3.83
YTD -$1.92
1Y -$1.06

UNCY was -21.5% over the past year, -49.7% over six months, -33.1% year to date, +8.1% in the last week.

12 Months vs Market
UNCY
-21.5%
DIA
+12.0%
SPY
+13.8%
QQQ
+16.2%
IWM
+11.4%

Over the past 12 months UNCY returned -21.5% versus DIA (Dow) +12.0%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +16.2% and IWM (Russell 2000) +11.4%.

Volume & Liquidity 0.16× 3-mo avg
Today 136,303 3-mo avg 863.4K
1W
1.2M
1M
991.5K
3M
863.4K
6M
1.2M
YTD
934.8K
1Y
834.5K

UNCY most recently traded 136,303 shares against a 3-month average daily volume of 863.4K.

More News

Read More
News headline image
Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
October 20, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY DEADLINE: SueWallSt Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
October 20, 2026
From SueWallSt
Via GlobeNewswire
News headline image
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
October 19, 2026
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
UNCY DEADLINE: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
October 16, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of November 2, 2026 in the Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Securities Class Action
October 16, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 2, 2026
October 14, 2026
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities Lawsuit - Contact SueWallSt
October 13, 2026
From SueWallSt
Via GlobeNewswire
News headline image
UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky
October 12, 2026
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to the Lead Plaintiff Deadline on November 2, 2026
October 12, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
October 11, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
UNCY Investor Alert: Unicycive Therapeutics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
October 09, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
October 08, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Unicycive Therapeutics, Inc. Investors with Large Losses to Contact the Firm Seeking Lead Plaintiff Role
October 08, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
October 07, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
October 05, 2026
Via Newsfile
Topics Lawsuit
News headline image
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
October 02, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
Kaplan Fox Class Action Reminder: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Lead Plaintiff Deadline is November 2, 2026
October 02, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Unicycive Therapeutics Appoints Meredith Manning to Board of Directors
October 01, 2026
Via B2i Digital
News headline image
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is November 2, 2026
September 30, 2026
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
September 29, 2026
Via B2i Digital
News headline image
Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role
September 28, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
September 25, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026
September 24, 2026
Via NewMediaWire
Topics Lawsuit

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
The current price of Unicycive Therapeutics, Inc. - Common Stock is 3.880
When was Unicycive Therapeutics, Inc. - Common Stock last traded?
The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 10/22/26 10:27 AM ET
What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 56.29M
How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
Unicycive Therapeutics, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap